您要查找的是不是:
- What are the factors that may guide the decision to select a specific antiplatelet agent to initiate first after ischemic stroke? 那么,在缺血性卒中后选择某一种特定药物开始抗血小板治疗时,需要考虑哪些因素?
- The use of buflomedil should be considered in addition to an antiplatelet agent in patients with peripheral arterial obstructive disease and intermittent claudication. 外周动脉阻塞性疾病和间歇性跛行患者应该在抗血小板治疗的基础上加用丁咯地尔。
- The safe alternative antiplatelet agent for long administration should be used if aspirin resistance appears, prediction of AR and individualization of antiplatelet therapy would be an emerging direction of antiplatelet therapy. ASA用于抗血小板治疗及预防动脉硬化事件的脑血管病患者,若有AR存在,应及时换用其它安全有效的抗血小板制剂,因阿司匹林需要长期应用,今后预测AR及抗血小板治疗个体化,将是未来抗血小板治疗的研究方向。
- Thromboembolic eent rates were haled among the 159 aneurysms in patients treated with acetylsalicylic acid compared to the 102 aneurysms in patients treated without the antiplatelet agent, the study authors reported on Thursday. 该研究的作者星期四报道,159名使用阿司匹林的动脉瘤患者与102名未使用抗血小板治疗的动脉瘤患者相比,血栓栓塞事件的发生率降低50%25。
- To investigate the bioactivity of W2002 as an antiplatelet agent, turbidimetric method and platelet count were used to determine the platelet aggregation induced by adenosine diphosphate(ADP) and high shear rate, respectively. 为探讨其抗血小板聚集的活性 ;分别用比浊法和血小板计数的方法测定二磷酸腺苷 (ADP)及高剪切速率诱导的血小板聚集 ;并用放射性配体分析法测定血小板表面结合 [12 5I]纤维蛋白原 (FGN)的含量 ;以了解 W2 0 0 2竞争性抑制 [12 5I]FGN与血小板糖蛋白 (GP) b/ a结合的生物活性 .
- Antiplatelet agents are not as effective as warfarin in reducing the risk of thromboembolism in patients with AF. 抗血小板制剂不能象华法林那样在房颤病中有效地减少血栓栓塞的危险。
- There is no evidence that antiplatelet agents reduce atherosclerotic risk in patients with HF. 没有任何证据表明,抗血小板制剂降低心衰患者动脉粥样硬化的危险。
- Anticoagulation use has increased in nontargeted, low-risk groups in whom antiplatelet agents are appropriate. 在那些接受抗血小板治疗更加合适的低危险组病人中,抗凝治疗的使用也呈增加趋势。
- Current therapies for arterial ischemic stroke include thrombolytic,antithrombotic and antiplatelet agents,blood transfusion and surgery. 目前治疗手段主要包括溶栓、抗凝、抗血小板、输血以及外科治疗。
- Novel and more potent antiplatelet agents currently under clinical development will be useful in efforts to reach these therapeutic goals. 随着临床的发展,当前新型的以及更为有效的抗血小板剂将有助于达到这些治疗的效果。
- Hence, particularly for women at high risk of preeclampsia, a more widespread use of antiplatelet agents may be worthwhile," she said. 因此,特别是对于她们来说,更广泛地应用抗血小板药物是值得的。”
- Clopidogrel,a new kind of antiplatelet agents,can reduce the occurrence of cardiovascular event and have key position in the treatment of cardiovascular disease. 氯吡格雷,作为一种新型的抗血小板制剂,能够明显减少心血管事件的发生,在冠心病的治疗中有着重要的地位。
- The PLA formation is affected variously by various antiplatelet agents.Monitoring of PLA formation is helpful in guiding the clinical use and selection of antiplatelet agents. 不同的抗血小板药物对PLA形成的影响有所差异,监测PLA有助于指导抗血小板药的临床应用和筛选。
- Reduced antiplatelet drug responsiveness, including resistance to currently used oral antiplatelet agents, has been suggested to play a role in these worse outcomes. 降低抗血小板药物反应性已被认为在这些更糟的结果的出现中起到了推波助澜的作用,其中就包括对目前常用口服抗血小板剂的抵制。
- Conclusions: Adjusted-dose warfarin and antiplatelet agents reduce stroke by approximately 60% and by approximately 20%, respectiely, in patients who hae atrial fibrillation. 结论:在房颤病人中,适量的华法林和抗血小板药的抗凝治疗分别减少了大约60%25和20%25的卒中发生率。
- Other beneficial factors about disease recurrence were concurrent use of calcium channel blocker (CCB), revascularization and prolong use of antiplatelet agents. 对于疾病再发的有益因子有:合并使用钙离子通道阻断剂、执行心脏手术、延长抗血小板凝集药物的使用天数。
- For patients with cryptogenic stroke associated with mobile aortic arch thrombi, we suggest either oral anticoagulation or antiplatelet agents (Grade 2C). 对于伴有主动脉弓活动性血栓的不明原因卒中患者,建议或者口服抗凝,或者服用抗血小板药物(2C级)。
- Also, unlike heart attacks, brain attacks are a misnomer, and include patients with a great variety of different etiologies, all with differing responses to antiplatelet agents. 另外,不像心脏病发作,脑发作是一个误称,包含各种各样对抗血小板药反应均不同的不同病因的患者。
- I booked my holiday through my local travel agent. 我是由本地的旅游代理人预先安排的度假事宜。
- The need of an ideal point-of-care( POC) blood coagulation analyzer increases rapidly due to the increased invasive medical procedures and the prescription of both antiplatelet agents and anticoagulants. 摘要随着医学的进步、活型态的改变及老年人口的增加,心脏血管疾病与血液凝固功能过高的疾病愈盛行之外,侵袭性的医疗手段及抑制凝血功能的药物也愈发达,因此检测血液凝固功能之可携式床边检测仪器的开发益形重要。